{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13"],"submitter":["Jin J"],"pubmed_abstract":["<b>Background:</b> Pharmacotherapy is one of the primary treatments for patients with Assisted reproductive technology (ART). Despite the publication of various research on ART treatment, there is no clear conclusion regarding the choice of drug treatment in China. Our research intends to examine the trend of widely prescribed medications for ART patients in China. For instance, the study examines the logic of drug indications, usage, and dose in patient prescriptions. <b>Methods:</b> We did a cross-sectional study of the data from the hospital prescription analysis cooperation project supervised by the China Medical Association. The information is extracted from the prescriptions of reproductive assistance outpatients from January 2016 to December 2020. We used the U.S. Food and Drug Admi"],"journal":["Frontiers in pharmacology"],"pagination":["1021150"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9713242"],"repository":["biostudies-literature"],"pubmed_title":["Real-world prescription patterns for reproductive assistance patients in China: A trend analysis from 2016 to 2020."],"pmcid":["PMC9713242"],"pubmed_authors":["Tang J","Zhu J","Jin J"],"additional_accession":[]},"is_claimable":false,"name":"Real-world prescription patterns for reproductive assistance patients in China: A trend analysis from 2016 to 2020.","description":"<b>Background:</b> Pharmacotherapy is one of the primary treatments for patients with Assisted reproductive technology (ART). Despite the publication of various research on ART treatment, there is no clear conclusion regarding the choice of drug treatment in China. Our research intends to examine the trend of widely prescribed medications for ART patients in China. For instance, the study examines the logic of drug indications, usage, and dose in patient prescriptions. <b>Methods:</b> We did a cross-sectional study of the data from the hospital prescription analysis cooperation project supervised by the China Medical Association. The information is extracted from the prescriptions of reproductive assistance outpatients from January 2016 to December 2020. We used the U.S. Food and Drug Admi","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-05T10:34:57.629Z","creation":"2025-02-19T04:34:03.738Z"},"accession":"S-EPMC9713242","cross_references":{"pubmed":["36467066"],"doi":["10.3389/fphar.2022.1021150"]}}